The proven technology to invest wisely

USA Change Macroaxis User Registration

HomePortfoliosSolutionsTools

Portfolio MasterPortfolio ManagerRebalancingPortfolio AnalyzerOptimizerSuggestion

US Market Closed: May 27, 01:22 AM 2012

MYL WPI MRX PRX AKRX HITK

NYSE 7,534 18.032

Processing
Collecting data for SLXP

Salix story

Companies

Insiders

Advisers

More Actions
- Equity Search
- Advanced Search
- Market Screener
- Adviser Directory
- Suggest Portfolio
- Backtest Watchlist
- Analyze Correlations
- View Transactions
- Check Volatility
- Import Equities

Salix Pharmaceuticals Ltd.

Stock@American Stock Exchange

Use Salix Pharmaceuticals Ltd. story together with your assets to enhance returns of your portfolios as well as to check it against diversification policy that fits your risk preferences.

Fees questioned: GRCC Board of Trustees opposes request for more information ...

At www.mlive.com

Fees questioned: GRCC Board of Trustees opposes request for more information ... The Grand Rapids Press - MLive.com - 15 hours ago By Brian McVicar | bmcvicar@mlive.com Cory Morse | MLive.comAmanda Duby is pictured with her GRCC Refund Access Card on the campus of Grand Rapids Community College Friday, February 10, 2012.

Story Momentum

This story impact on price volatility cannot be determined at this time. Please check this story after some time to allow current data to be analyzed.

Price

Timeline

Similar stores for Salix

Few days ago at www.itbusinessnet.com

View

Analyst Moves: SLXP, WYNN

IT Business Net - May 10, 2012 By GrabNetworks Salix Pharmaceuticals (SLXP) today had its estimates increased by Jefferies (JEF) after the company beat earnings estimates.

Few days ago at zolmax.com

View

Zacks Reiterates Neutral on Salix Pharmaceuticals (SLXP)

Junction Report - May 9, 2012 Salix Pharmaceuticals (NASDAQ: SLXP)'s stock had its ?neutral? rating restated by Zacks in a report issued on Wednesday. They currently have a $55.00 target price on the stock. Auriga Reiterates Hold on Salix Pharmaceuticals (SLXP) - Movie News Guide (blog)

Few days ago at www.streetinsider.com

View

Jefferies Boosts Price Target on Salix Pharmaceuticals (SLXP)

StreetInsider.com (subscription) - May 8, 2012 Jefferies analysts raised their price target on Salix Pharmaceuticals (NASDAQ: SLXP) from $54.00 to $63.00 while maintaining a BUY rating on the company.

Discuss Salix story

Follow Salix News with your standard RSS feed, custom widget, or your favorite social app

Get Widget

Syndicate

Salix News

Salix Research Report

Beta Comparison

Beta is one of the most important measures of equity market volatility. Beta can be thought of as asset elasticity or sensitivity to market. In other words, it is a number that shows the relationship of financial instrument to the financial market in which this instrument is traded. For example if Beta of equity is 2, it will be expected to significantly outperform market when market is going up and significantly underperform when market is going down. Similarly, Beta of 1 indicates that an asset and market will generate similar returns during over time.

More...